University of Liverpool Medical School, Liverpool, UK; The Walton Centre NHS Foundation Trust for Neurology and Neurosurgery, Liverpool, UK.
The Walton Centre NHS Foundation Trust for Neurology and Neurosurgery, Liverpool, UK; Functional Neurosurgery Department, Universidade de Caxias do Sul, Brazil.
J Neurol Sci. 2023 Sep 15;452:120752. doi: 10.1016/j.jns.2023.120752. Epub 2023 Jul 31.
Cervical Dystonia ("CD") is a movement disorder characterised by sustained muscle contractions in the neck, causing involuntary posturing. Deep brain stimulation ("DBS") of the globus pallidal internus (GPi) is advanced treatment for pharmaco-refractory patients. As CD is a rare disease, cohort studies are often limited to patients of heterogenous disease profile, small sample size or short follow-up. This study firstly aimed to measure the efficacy of GPi-DBS on motor and non-motor symptoms of CD. A secondary aim was to evaluate if clinical factors - such as age, disease duration and baseline disease severity - influence variability of motor outcomes.
37 idiopathic CD patients were recruited from movement disorders clinics at The Walton NHS Foundation Trust, Liverpool, UK. Patients were assessed pre-operatively, and 1 year, 3 years and 5 years post-operatively with the following clinical scales: Toronto Western Spasmodic Torticollis Rating Scale ("TWSTRS"), Hospital Anxiety and Depression Scale and EuroQuol-5D.
GPI-DBS significantly improved overall TWSTRS scores by 57% from baseline to 5Y FU (p < 0.001). It also significantly improved TWSTRS severity, disability, and pain sub-scores by 72%, 59% and 46% respectively. We did not find a significant improvement in mood or quality of life scores at 5 years. Similarly, clinical factors at baseline did not correlate with variability in motor outcome.
We concluded that GPi-DBS is an effective treatment for motor symptoms and pain in CD. There was limited effect on mood and QoL, and no clinical predictive factors of outcome were identified.
颈肌张力障碍(“CD”)是一种以颈部肌肉持续收缩为特征的运动障碍,导致不自主的姿势。苍白球 internus(GPi)深部脑刺激(“DBS”)是药物难治性患者的先进治疗方法。由于 CD 是一种罕见疾病,队列研究通常限于疾病谱异质、样本量小或随访时间短的患者。本研究首先旨在测量 GPi-DBS 对 CD 的运动和非运动症状的疗效。次要目的是评估临床因素(如年龄、疾病持续时间和基线疾病严重程度)是否会影响运动结果的变异性。
37 名特发性 CD 患者从英国利物浦沃尔顿国民保健信托基金会的运动障碍诊所招募。患者在术前、术后 1 年、3 年和 5 年进行评估,使用以下临床量表:多伦多西部痉挛性斜颈评分量表(“TWSTRS”)、医院焦虑和抑郁量表和 EuroQuol-5D。
从基线到 5 年 FU,GPi-DBS 使总体 TWSTRS 评分显著改善 57%(p<0.001)。它还使 TWSTRS 严重程度、残疾和疼痛子量表分别显著改善 72%、59%和 46%。我们没有发现 5 年后情绪或生活质量评分的显著改善。同样,基线时的临床因素与运动结果的变异性无关。
我们得出结论,GPi-DBS 是治疗 CD 运动症状和疼痛的有效方法。对情绪和 QoL 的影响有限,并且没有确定与结果相关的临床预测因素。